LOGO
LOGO

OptimizeRx Stock Delivers Over 90% Gain In Six Months - A Prescription For Portfolio Growth?

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
doc 24102025 lt

Brand visibility of pharmaceutical products to healthcare providers remains one of the toughest challenges in today's competitive pharmaceutical market. Sales representatives have less face-to-face time with prescribers as healthcare providers spend much of their day in front of computers and in the EHR (electronic health record) systems, making it harder for direct engagement and brand promotion.

Further, EHRs do not often communicate with one another, creating interoperability
issues that prevent healthcare providers from accessing all relevant patient information. In addition, expensive specialty medications are becoming more common and involve more complex diagnosis criteria, contributing to substantial script abandonment by patients.

Subscribe to continue reading the article.
This article is available exclusively to RTT Biotech Investor and Intelligent Investor subscribers. Subscribe with a RTTNews subscription.
Start Free Trial
FREE 7-Day Trial - No Payment Required
Already subscribed? Sign in

For comments and feedback contact: editorial@rttnews.com

Global Economics Weekly Update -June 15 - June 19, 2026

June 19, 2026 16:46 ET
Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.